Search

What do I need to know about antibody testing?
How long before I know if gene therapy is helping?
How is safety monitored after gene therapy?
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments
A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
How personal experience shapes support for Duchenne families
Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year